Social media platform Truth Social is one of the few places left for former President Donald Trump to share his thoughts and opinions.
Here’s a look at how the company could soon be expanding its reach.
Rain Therapeutics (NASDAQ: RAIN) has completed patient enrolment in its Phase 3 MANTRA trial of its lead asset, milademetan for well-differentiated / dedifferentiated (WD/DD) liposarcoma (LPS).
For the first time since April, purchase mortgage rates dropped below the 5% level, reflecting the Federal Reserve’s monetary policy that has led the U.S economy to a “technical recession.”